Intravitreal Injection Technique [PDF]
MedEdPORTAL, 2016 Intravitreal injection of therapeutic medications has become one of the most commonly performed procedures in ophthalmology. Over the past decade, a number of guidelines have been published that recommend proper techniques to increase the safety of intravitreal injections.
Joanne C Wen, Kasra A. Rezaei
openaire +5 more sources
Endophthalmitis following intravitreal injections at a tertiary center: real-life data on incidence, risk factors, management strategies, and visual outcomes. [PDF]
BMC OphthalmolPurpose To investigate the incidence, contributing factors, management, and long-term outcomes of endophthalmitis following intravitreal injections performed in our clinic.
Comcali S +10 more
europepmc +2 more sources
Effect of intravitreal injections due to neovascular age-related macular degeneration on retinal nerve fiber layer thickness and minimum rim width: a cross sectional study. [PDF]
BMC OphthalmolPurpose The present study tested the hypothesis that repeated anti-VEGF injections are associated with reduced retinal nerve fiber layer (RNFL) and minimum rim width (MRW) of the optic nerve head. Patients and methods Sixty-six patients with a history of
Boltz A +4 more
europepmc +2 more sources
ANTISEPTICS AT INTRAVITREAL INJECTIONS
Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук, 2016 Authors analyze efficiency of application antiseptics of a miramistin in prevention of infectious complications in case of repeated intravitreal injections of VEGF inhibitor Ranibizumab in 156 patients with the age related macular de-generation. 0,01% solution of antiseptic Miramistin (Okomistin®) was instillated 4 times per day two days before ...
Ayna Ozderbaeva +5 more
openaire +4 more sources
Real-world incidence of endopthalmitis after intravitreal anti-VEGF injections in Korea: findings from the Common Data Model in ophthalmology [PDF]
Epidemiology and Health, 2021 OBJECTIVES The aim of this study was to evaluate the real-world incidence of endophthalmitis after intravitreal anti-vascular endothelial growth factor (VEGF) injections using data from the Observational Medical Outcomes Partnership (OMOP) Common Data ...
Yongseok Mun +15 more
doaj +1 more source
Clinical outcomes of intravitreal treatment for ocular toxoplasmosis: systematic review and meta-analysis [PDF]
Revista da Sociedade Brasileira de Medicina Tropical, 2023 Background: Ocular toxoplasmosis is the leading cause of infectious posterior uveitis worldwide, accounting for 30-50% of all cases in immunocompetent patients.
Lutiana Amaral de Melo +5 more
doaj +1 more source
Intravitreal injections: A brief note
Kerala Journal of Ophthalmology, 2018 The delivery of medications directly into the vitreous cavity through an injection or implant has become a commonplace in ophthalmology. Common diseases treated by intravitreal injections include neovascular age-related macular degeneration, clinically significant macular edema/proliferative diabetic retinopathy, cystoid macular edema following retinal
Anu Joseph
openaire +4 more sources
Case Reports in Ophthalmology, 2021 Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) is essential for the treatment of macular diseases such as wet age-related macular degeneration and macular edema.
Atsuta Ozaki +5 more
doaj +1 more source
Acute systemic complications of intravitreal bevacizumab and triamcinolone injections – a comparative study [PDF]
Folia Medica, 2022 Introduction: Macular edema is a common visual threatening complication in patients with diabetic retinopathy and retinal vein occlusion. The injection of intravitreal drugs, such as anti-vascular endothelial growth factor (anti-VEGF) and corticosteroids,
Mohammad Karim Johari +3 more
doaj +3 more sources
Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusion [PDF]
International Journal of Ophthalmology, 2016 AIM: To evaluate the association between the size of peripheral retinal non-perfusion and the number of intravitreal ranibizumab injections in patients with treatment-naive branch retinal vein occlusion (BRVO) and macular edema.
Kaveh Abri Aghdam +7 more
doaj +1 more source